DocGo Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| DOCGO INC. | ||
| Date: February 27, 2025 | By: | /s/ Lee Bienstock |
|---|---|---|
| Lee Bienstock | ||
| Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Lee Bienstock | Chief Executive Officer and Director | February 27, 2025 |
| Lee Bienstock | (principal executive officer) | |
| /s/ Norman Rosenberg | Chief Financial Officer | February 27, 2025 |
| Norman Rosenberg | (principal financial and accounting officer) | |
| /s/ Stephen K. Klasko | Chair of the Board | February 27, 2025 |
| Stephen K. Klasko | ||
| /s/ Michael Burdiek | Director | February 27, 2025 |
| Michael Burdiek | ||
| /s/ Vina Leite | Director | February 27, 2025 |
| Vina Leite | ||
| /s/ Ira Smedra | Director | February 27, 2025 |
| Ira Smedra | ||
| /s/ Ely D. Tendler | Director | February 27, 2025 |
| Ely D. Tendler | ||
| /s/ James M. Travers | Director | February 27, 2025 |
| James M. Travers | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.